brph institucional agosto v11 eng v3
DESCRIPTION
TRANSCRIPT
![Page 1: Brph institucional agosto v11 eng v3](https://reader033.vdocuments.us/reader033/viewer/2022050919/546e3ef0af79597b298b5670/html5/thumbnails/1.jpg)
![Page 2: Brph institucional agosto v11 eng v3](https://reader033.vdocuments.us/reader033/viewer/2022050919/546e3ef0af79597b298b5670/html5/thumbnails/2.jpg)
![Page 3: Brph institucional agosto v11 eng v3](https://reader033.vdocuments.us/reader033/viewer/2022050919/546e3ef0af79597b298b5670/html5/thumbnails/3.jpg)
![Page 4: Brph institucional agosto v11 eng v3](https://reader033.vdocuments.us/reader033/viewer/2022050919/546e3ef0af79597b298b5670/html5/thumbnails/4.jpg)
20
03
20
04
20
05
20
06
20
07
20
08
20
09
20
10
20
11
20
12
e
20
13
e
20
14
e
20
15
e
20
16
e
20
17
e
20
18
e
20
19
e
20
20
e
![Page 5: Brph institucional agosto v11 eng v3](https://reader033.vdocuments.us/reader033/viewer/2022050919/546e3ef0af79597b298b5670/html5/thumbnails/5.jpg)
-20% -10% 0% 10% 20%
0 - 9
10 - 19
20 - 29
30 - 39
40 - 49
50 - 59
60 - 69
70 - 79
80+
Europe 2010 Brazil 2030
-20% -10% 0% 10% 20%
0 - 910 - 1920 - 2930 - 3940 - 4950 - 5960 - 6970 - 79
80+
Europe 2010 Brazil 2010
![Page 6: Brph institucional agosto v11 eng v3](https://reader033.vdocuments.us/reader033/viewer/2022050919/546e3ef0af79597b298b5670/html5/thumbnails/6.jpg)
![Page 7: Brph institucional agosto v11 eng v3](https://reader033.vdocuments.us/reader033/viewer/2022050919/546e3ef0af79597b298b5670/html5/thumbnails/7.jpg)
![Page 8: Brph institucional agosto v11 eng v3](https://reader033.vdocuments.us/reader033/viewer/2022050919/546e3ef0af79597b298b5670/html5/thumbnails/8.jpg)
![Page 9: Brph institucional agosto v11 eng v3](https://reader033.vdocuments.us/reader033/viewer/2022050919/546e3ef0af79597b298b5670/html5/thumbnails/9.jpg)
![Page 10: Brph institucional agosto v11 eng v3](https://reader033.vdocuments.us/reader033/viewer/2022050919/546e3ef0af79597b298b5670/html5/thumbnails/10.jpg)
![Page 11: Brph institucional agosto v11 eng v3](https://reader033.vdocuments.us/reader033/viewer/2022050919/546e3ef0af79597b298b5670/html5/thumbnails/11.jpg)
![Page 12: Brph institucional agosto v11 eng v3](https://reader033.vdocuments.us/reader033/viewer/2022050919/546e3ef0af79597b298b5670/html5/thumbnails/12.jpg)
1 1
72881109
96
90333
1
![Page 13: Brph institucional agosto v11 eng v3](https://reader033.vdocuments.us/reader033/viewer/2022050919/546e3ef0af79597b298b5670/html5/thumbnails/13.jpg)
![Page 14: Brph institucional agosto v11 eng v3](https://reader033.vdocuments.us/reader033/viewer/2022050919/546e3ef0af79597b298b5670/html5/thumbnails/14.jpg)
Shares under lock-up
![Page 15: Brph institucional agosto v11 eng v3](https://reader033.vdocuments.us/reader033/viewer/2022050919/546e3ef0af79597b298b5670/html5/thumbnails/15.jpg)
![Page 16: Brph institucional agosto v11 eng v3](https://reader033.vdocuments.us/reader033/viewer/2022050919/546e3ef0af79597b298b5670/html5/thumbnails/16.jpg)
![Page 17: Brph institucional agosto v11 eng v3](https://reader033.vdocuments.us/reader033/viewer/2022050919/546e3ef0af79597b298b5670/html5/thumbnails/17.jpg)
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
![Page 18: Brph institucional agosto v11 eng v3](https://reader033.vdocuments.us/reader033/viewer/2022050919/546e3ef0af79597b298b5670/html5/thumbnails/18.jpg)
MAPPING
PLUG-IN
CONTINUOUS IMPROVEMENT
1
2
3
Admission to Termination
Calculation and Collection
Calculating Results
Administrative-Financial
Administrative Support
IT Support
PA
S
Ce
nte
r S
ha
red
Serv
ices -
SS
C
•
•
![Page 19: Brph institucional agosto v11 eng v3](https://reader033.vdocuments.us/reader033/viewer/2022050919/546e3ef0af79597b298b5670/html5/thumbnails/19.jpg)
•
•
•
•
•
•
![Page 20: Brph institucional agosto v11 eng v3](https://reader033.vdocuments.us/reader033/viewer/2022050919/546e3ef0af79597b298b5670/html5/thumbnails/20.jpg)
•
•
•
•
•
•
•
•
•
•
•
••
•
•
![Page 21: Brph institucional agosto v11 eng v3](https://reader033.vdocuments.us/reader033/viewer/2022050919/546e3ef0af79597b298b5670/html5/thumbnails/21.jpg)
Dermocosmetics space to displays
premium products
Gondola point: Clusterizing stores by customer
profile to maximize potential of products
exposure
Check-out display: High turnover products to
encourage impulse purchase
Category management: Intelligence organization
depending on consumption drive
![Page 22: Brph institucional agosto v11 eng v3](https://reader033.vdocuments.us/reader033/viewer/2022050919/546e3ef0af79597b298b5670/html5/thumbnails/22.jpg)
![Page 23: Brph institucional agosto v11 eng v3](https://reader033.vdocuments.us/reader033/viewer/2022050919/546e3ef0af79597b298b5670/html5/thumbnails/23.jpg)
![Page 24: Brph institucional agosto v11 eng v3](https://reader033.vdocuments.us/reader033/viewer/2022050919/546e3ef0af79597b298b5670/html5/thumbnails/24.jpg)
EVOLUTION OF FARMAIS STORE BASE
FARMAIS EXPANSION
![Page 25: Brph institucional agosto v11 eng v3](https://reader033.vdocuments.us/reader033/viewer/2022050919/546e3ef0af79597b298b5670/html5/thumbnails/25.jpg)
•
•
•
![Page 26: Brph institucional agosto v11 eng v3](https://reader033.vdocuments.us/reader033/viewer/2022050919/546e3ef0af79597b298b5670/html5/thumbnails/26.jpg)
![Page 27: Brph institucional agosto v11 eng v3](https://reader033.vdocuments.us/reader033/viewer/2022050919/546e3ef0af79597b298b5670/html5/thumbnails/27.jpg)
FINANCIAL RESULTS OPERATIONAL RESULTS
![Page 28: Brph institucional agosto v11 eng v3](https://reader033.vdocuments.us/reader033/viewer/2022050919/546e3ef0af79597b298b5670/html5/thumbnails/28.jpg)
132
210
118
248
249
96 29
15 2
2011 Aquisição Cresc. orgânico Fechamento Cresc. orgânico Fechamento 2012
132
210
118
248
249
96 29
15 2
2011 Aquisição Cresc. orgânico Fechamento Cresc. orgânico Fechamento 2012
1
132
210
118
248
249
67 29
132
2011 Acquisition Organic growth Closing 9M12 Organic growth Closing 2012
378
681708
132
210
118
248
249
67 29
132
2011 Acquisition Organic growth Closing 9M12 Organic growth Closing 2012
378
681708
132
210
118
248
249
67 29
132
2011 Acquisition Organic growth Closing 9M12 Organic growth Closing 2012
378
681708
132
210
118
248
249
67 29
132
2011 Acquisition Organic growth Closing 9M12 Organic growth Closing 2012
378
681708
132
210
118
248
249
67 29
132
2011 Acquisition Organic growth Closing 9M12 Organic growth Closing 2012
378
681708
378
708
![Page 29: Brph institucional agosto v11 eng v3](https://reader033.vdocuments.us/reader033/viewer/2022050919/546e3ef0af79597b298b5670/html5/thumbnails/29.jpg)
![Page 30: Brph institucional agosto v11 eng v3](https://reader033.vdocuments.us/reader033/viewer/2022050919/546e3ef0af79597b298b5670/html5/thumbnails/30.jpg)
![Page 31: Brph institucional agosto v11 eng v3](https://reader033.vdocuments.us/reader033/viewer/2022050919/546e3ef0af79597b298b5670/html5/thumbnails/31.jpg)
![Page 32: Brph institucional agosto v11 eng v3](https://reader033.vdocuments.us/reader033/viewer/2022050919/546e3ef0af79597b298b5670/html5/thumbnails/32.jpg)
![Page 33: Brph institucional agosto v11 eng v3](https://reader033.vdocuments.us/reader033/viewer/2022050919/546e3ef0af79597b298b5670/html5/thumbnails/33.jpg)
![Page 34: Brph institucional agosto v11 eng v3](https://reader033.vdocuments.us/reader033/viewer/2022050919/546e3ef0af79597b298b5670/html5/thumbnails/34.jpg)
Working capial 2Q12 4Q12 1Q13 2Q13
Accounts receivable 25 23 24 18
Inventories 92 95 106 109
Suppliers 54 58 55 73
Working capital in days 63 60 75 53
Cash position and indebtedness (R$'000) 2Q12 4Q12 1Q13 2Q13
(+) Loans and financing 159,908 177,049 169,079 160,228
Short term 48,123 83,229 44,864 41,694
Long term 111,785 93,820 124,215 118,534
(+) Debentures 254,879 253,642 258,937 253,964
Short term 6,688 5,237 10,427 5,348
Long term 248,191 248,405 248,510 248,616
(+) Accounts payable for investment acquisition 498,242 345,333 264,430 232,581
Short term 244,986 99,711 82,833 81,986
Long term 253,256 245,622 181,597 150,595
(=) Total Indebtedness 913,029 776,024 692,446 646,773
Short term (%) 32.8% 24.2% 19.9% 19.9%
Long term (%) 67.2% 75.8% 80.1% 80.1%
(-) Cash and cash equivalents (411,267) (368,751) (183,870) (162,205)
(=) Net Debt 501,762 407,273 508,576 484,568
Net debt/Adjusted EBITDA (LTM) 2.9 X 2.1 X 2.7 X 2.5 X
![Page 35: Brph institucional agosto v11 eng v3](https://reader033.vdocuments.us/reader033/viewer/2022050919/546e3ef0af79597b298b5670/html5/thumbnails/35.jpg)
![Page 36: Brph institucional agosto v11 eng v3](https://reader033.vdocuments.us/reader033/viewer/2022050919/546e3ef0af79597b298b5670/html5/thumbnails/36.jpg)
4.7 3.0
2.2 1.1
2.3 1.9 1.0 2.1 3.0 1.5 3.1
4.1 5.2
6.9
6.8
13.4
11.3
7.5
6.3
15.3 11.4
12.6
10.1
12.0 8.0
7.0 7.4
6.9 7.8 8.1
8.6 8.4 9.3
10.5 10.1 9.8
11.2
12.1 12.3 12.3
13.1 13.6
14.4 15.1
14.6
13.1 12.7
11.0
Jul-1
1
Aug-1
1
Sep-1
1
Oct-
11
No
v-1
1
De
c-1
1
Jan-1
2
Feb
-12
Ma
r-1
2
Apr-
12
Ma
y-1
2
Jun-1
2
Jul-1
2
Aug-1
2
Sep-1
2
Oct-
12
No
v-1
2
De
c-1
2
Jan-1
3
Feb
-13
Ma
r-1
3
Apr-
13
Ma
y-1
3
Jun-1
3
Vol. R$ Médio diário (Milhão)
P. Médio (R$/ação)
Ju
n-1
1
Ju
l-1
1
Aug
-11
Sep
-11
Oct-
11
Nov-1
1
Dec-1
1
Ja
n-1
2
Feb-1
2
Ma
r-12
Apr-
12
Ma
y-1
2
Ju
n-1
2
Ju
l-1
2
Aug
-12
Sep
-12
Oct-
12
Nov-1
2
Dec-1
2
Ja
n-1
3
Feb-1
3
Ma
r-13
Apr-
13
Ma
y-1
3
Ju
n-1
3
Brasil Pharma
IBOV
BPHA3 06.30.13 Market closure
Shares outstanding 256.384.419
Price (R$/share) 10.26
Annual Performance -28.8%
Ibovespa Index -22.1%
Perfomance since IPO¹ 19.0%
Ibovespa Index -22.2%
Market Cap (R$ Bn) 2.6
Average daily trading volume in 2013 (R$ million) 12.4
2013 2014 2015
Brasil Pharma 13,5x 9,7x 7,7x
2013 2014 2015
Brasil Pharma 0,8x 0,7x 0,6x
2013 2014 2015
Brasil Pharma 32,4x 17,3x 12,3x
EV/EBITDA
EV/Sales
P/E
![Page 37: Brph institucional agosto v11 eng v3](https://reader033.vdocuments.us/reader033/viewer/2022050919/546e3ef0af79597b298b5670/html5/thumbnails/37.jpg)
•
•
•
•
•
•
•
•
•
•
•
![Page 38: Brph institucional agosto v11 eng v3](https://reader033.vdocuments.us/reader033/viewer/2022050919/546e3ef0af79597b298b5670/html5/thumbnails/38.jpg)
![Page 39: Brph institucional agosto v11 eng v3](https://reader033.vdocuments.us/reader033/viewer/2022050919/546e3ef0af79597b298b5670/html5/thumbnails/39.jpg)
5.8 6.2 6.0 6.3 6.5 5.8 5.8 8.5 9.3
13.9
19.2
11.8 15.2
11.8
6.7 8.3 10.6 9.0 9.5 11.4 7.1
7.0
9.9 11.0 10.4 12.0
34.0
11.7 12.4 12.3
26.7 30.7
45.6
25.7
33.3
19.0 14.3
17.5 21.9
19.1 18.0 19.2
11.8 12.3
0
10000
20000
30000
40000
50000
60000
0
1000
2000
3000
4000
5000
6000
7000
6.2
8.9 7.8
10.4 10.3 9.2
7.9 9.2
10.8
15.1
18.5 18.9
22.8 21.3
18.1
14.6 14.0 15.6 14.8
11.8
8.8 7.5
21
11.4
16.2 14.2
19.2 18.9 16.6
14.1 16.2
18.6
24.6
30.4 29.8
37.5
34.8
29.9
24 22.9
26.3
23.8
21.1 18.8
0
10000
20000
30000
40000
50000
19
87
19
88
19
89
19
90
19
91
19
92
19
93
19
94
19
95
19
96
19
97
19
98
19
99
20
00
20
01
20
02
20
03
20
04
20
05
20
06
20
07
0
500
1000
1500
2000
2500
3000
3500
4000
4500
5,8 6,2 6,0 6,3 6,5 5,8 5,88,5 9,3
13,9
19,2
11,8
15,2
11,8
6,78,3
10,69,0 9,5
11,4
7,1
7,0
9,9 11,0 10,412,0
34,0
11,7 12,4 12,3
26,7
30,7
45,6
25,7
33,3
19,0
14,3
17,5
21,919,1
18,019,2
11,8 12,3
0,0
10000,0
20000,0
30000,0
40000,0
50000,0
60000,0
1987
1988
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
market cap EV/EBITDA P/E
0,0
1000,0
2000,0
3000,0
4000,0
5000,0
6000,0
7000,0
CVS CAREMARK
EBITDA
![Page 40: Brph institucional agosto v11 eng v3](https://reader033.vdocuments.us/reader033/viewer/2022050919/546e3ef0af79597b298b5670/html5/thumbnails/40.jpg)